CNBX Pharmaceuticals Inc. Quarterly Common Stock, Shares Authorized from Q3 2010 to Q4 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
CNBX Pharmaceuticals Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q3 2010 to Q4 2024.
  • CNBX Pharmaceuticals Inc. Common Stock, Shares Authorized for the quarter ending November 30, 2024 was 900M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 900M 0 0% Nov 30, 2024 10-Q 2025-01-13
Q3 2024 900M 0 0% Aug 31, 2024 10-Q 2025-01-13
Q2 2024 900M 0 0% May 31, 2024 10-Q 2024-07-15
Q1 2024 900M 0 0% Feb 29, 2024 10-Q 2024-04-16
Q4 2023 900M 0 0% Nov 30, 2023 10-Q 2024-01-12
Q3 2023 900M 0 0% Aug 31, 2023 10-K 2024-11-29
Q2 2023 900M 0 0% May 31, 2023 10-Q 2023-07-14
Q1 2023 900M 0 0% Feb 28, 2023 10-Q 2023-04-14
Q4 2022 900M 0 0% Dec 31, 2022 10-Q 2023-04-14
Q3 2022 900M 0 0% Aug 31, 2022 10-K 2023-11-30
Q2 2022 900M 0 0% May 31, 2022 10-Q 2022-07-14
Q1 2022 900M 0 0% Feb 28, 2022 10-Q 2022-04-12
Q4 2021 900M 0 0% Nov 30, 2021 10-Q 2022-01-13
Q3 2021 900M 0 0% Aug 31, 2021 10-K 2022-11-30
Q2 2021 900M 0 0% May 31, 2021 10-Q 2021-07-14
Q1 2021 900M 0 0% Feb 28, 2021 10-Q 2021-04-14
Q4 2020 900M 0 0% Nov 30, 2020 10-Q 2021-01-14
Q3 2020 900M 0 0% Aug 31, 2020 10-K 2021-11-29
Q2 2020 900M 0 0% May 31, 2020 10-Q 2020-07-14
Q1 2020 900M 0 0% Feb 29, 2020 10-Q 2020-04-13
Q4 2019 900M 0 0% Nov 30, 2019 10-Q 2020-01-14
Q3 2019 900M 0 0% Aug 31, 2019 10-K 2020-11-04
Q2 2019 900M 0 0% May 31, 2019 10-Q 2019-07-15
Q1 2019 900M 0 0% Feb 28, 2019 10-Q 2019-04-15
Q4 2018 900M 0 0% Nov 30, 2018 10-Q 2019-01-17
Q3 2018 900M 0 0% Aug 31, 2018 10-K 2019-11-29
Q2 2018 900M 0 0% May 31, 2018 10-Q 2018-07-16
Q1 2018 900M 0 0% Feb 28, 2018 10-Q 2018-04-05
Q4 2017 900M 0 0% Nov 30, 2017 10-Q 2018-01-16
Q3 2017 900M 0 0% Aug 31, 2017 10-K 2018-11-29
Q2 2017 900M 0 0% May 31, 2017 10-Q 2017-07-17
Q1 2017 900M 0 0% Feb 28, 2017 10-Q 2017-04-14
Q4 2016 900M 0 0% Nov 30, 2016 10-Q 2017-01-17
Q3 2016 900M 0 0% Aug 31, 2016 10-K 2017-12-08
Q2 2016 900M 0 0% May 31, 2016 10-Q 2016-07-13
Q1 2016 900M 0 0% Feb 29, 2016 10-Q 2016-04-18
Q4 2015 900M 0 0% Nov 30, 2015 10-Q/A 2016-04-08
Q3 2015 900M 0 0% Aug 31, 2015 10-K 2016-12-13
Q2 2015 900M 0 0% May 31, 2015 10-Q/A 2015-11-17
Q1 2015 900M 0 0% Feb 28, 2015 10-Q/A 2015-11-17
Q4 2014 900M 0 0% Nov 30, 2014 10-Q/A 2015-11-17
Q3 2014 900M 0 0% Aug 31, 2014 10-K 2016-01-07
Q2 2014 900M 0 0% May 31, 2014 10-Q/A 2014-07-15
Q1 2014 900M 0 0% Feb 28, 2014 10-Q 2014-04-01
Q4 2013 900M 0 0% Nov 30, 2013 10-Q 2014-01-14
Q3 2013 900M 0 0% Aug 31, 2013 10-K/A 2015-10-23
Q2 2013 900M May 31, 2013 10-Q 2013-07-15
Q1 2013 900M 0 0% Feb 28, 2013 10-Q 2013-04-15
Q4 2012 900M 0 0% Nov 30, 2012 10-Q 2013-01-14
Q3 2012 900M 0 0% Aug 31, 2012 10-K 2013-11-29
Q1 2012 900M Feb 29, 2012 10-Q 2012-04-13
Q4 2011 900M Nov 30, 2011 10-Q 2012-01-13
Q3 2011 900M 0 0% Aug 31, 2011 10-K 2012-11-30
Q2 2011 900M May 31, 2011 10-Q 2012-07-06
Q3 2010 900M Aug 31, 2010 10-Q 2012-07-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.